{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-26-000091","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2026-09-14T20:02:18+00:00","discovered_at":"2026-09-14T20:03:31.642187+00:00","generated_at":"2026-09-14T20:03:50.160707+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Emergent BioSolutions CEO presentation at H.C. Wainwright provides no new financial details","bullets":["Joseph C. Papa, President and CEO, to present at H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026.","Investor presentation furnished as Exhibit 99.1, titled 'Combating Public Health Threats for Communities Around the World'.","No specific financial data, guidance, or operational updates appear in the furnished presentation.","Filing is a Regulation FD disclosure with no other material corporate developments."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-26-000091","json":"https://secwatch.observer/filing/0001367644-26-000091.json","markdown":"https://secwatch.observer/filing/0001367644-26-000091.md","text":"https://secwatch.observer/filing/0001367644-26-000091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764426000091/0001367644-26-000091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764426000091/ebs-20260914.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T20:03:50.160707+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}